Newsletter

SOPHARMA AD (170/2023) A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the LPOS requiring prior approval by the public company

29.09.2023, 13:57aktualizacja: 29.09.2023, 13:58

Pobierz materiał i Publikuj za darmo

Report no 170/2023

Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.

"Sopharma" AD (the Company) informs that, after a request made to the parent company, public company "Sopharma" AD by the subsidiary "Pharmalogistika" AD and consent given by the Board of Directors from 12.09.2023, today the subsidiary concluded the following transaction falling within the scope of Art. 114, para. 3 of the LPOS:

1. "Pharmalogistika" AD, UIC 130959211, as the lessor, concluded a contract with "Sopharma Trading " AD, UIC 103267194 for the lease of a separate part with an area of 3,451.30 sq.m. from a plot of land with address Sofia, Rozhen Blvd No. 16, for a monthly rental price of BGN 3,800 (three thousand eight hundred) excluding VAT for a period of 3 /three/ years, starting from 01.10.2023 and functionally connected premises, for production, storage, office and service purposes with a total rental area of 80.80 sq.m. located in the city of Sofia, Rozhen Blvd No. 16 for a monthly rental price of BGN 347.00 (three hundred and forty-seven) excluding VAT for a period of 3 /three/ years, which will be paid monthly by bank transfer .

A) Stakeholder participation:

- Boris Anchev Borisov, who is a member of the Board of Directors of "Pharmalogistika" AD, and at the same time is a Procurator of "Sopharma Trading" AD - grounds for interest under Art. 114, para. 7, item 3 of the LPOS.

B) Value of the transaction:

The market price of the leased property is determined according to a market valuation prepared by an independent appraiser under Art. 5 of The Law of Independents Appraisers.

C) Assessment of the applicability of the conditions under Art. 114, para. 3, item 1 of the LPOS: The value of the described transaction exceeds the threshold under Art. 114, para. 3, item 1 b. b) of LPOS, which is why prior approval by the parent company, a public company, is required.

D) Assessment of the applicability of Art. 114 para. 6 of the LPOS:

Value of the assets provided for use, under the considered transaction with "Sopharma Trading" AD under the current request in BGN BGN 88,801

Value of the assets provided for use, according to a previously concluded transaction with the same legal person under, subject to cumulation under Art. 114, para. 6 of the LPOS BGN 88,137

Total value with cumulation under Art. 114, para. 6 of the LPOS of the assets provided for use BGN 176,938

Threshold under Art. 114, para. 3, item 1, b. "b" BGN 107,950

Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1

kom espi zdz

Pobierz materiał i Publikuj za darmo

bezpośredni link do materiału
Data publikacji 29.09.2023, 13:57
Źródło informacji ESPI
Zastrzeżenie Za materiał opublikowany w serwisie PAP MediaRoom odpowiedzialność ponosi – z zastrzeżeniem postanowień art. 42 ust. 2 ustawy prawo prasowe – jego nadawca, wskazany każdorazowo jako „źródło informacji”. Informacje podpisane źródłem „PAP MediaRoom” są opracowywane przez dziennikarzy PAP we współpracy z firmami lub instytucjami – w ramach umów na obsługę medialną. Wszystkie materiały opublikowane w serwisie PAP MediaRoom mogą być bezpłatnie wykorzystywane przez media.

Newsletter

Newsletter portalu PAP MediaRoom to przesyłane do odbiorców raz dziennie zestawienie informacji prasowych, komunikatów instytucji oraz artykułów dziennikarskich, które zostały opublikowane na portalu danego dnia.

ZAPISZ SIĘ